FLONURISE 15 mg/ 6,14 mg comprimido recubierto Uruguay - spansk - Ministerio de Salud (Dirección Oficina Central)

flonurise 15 mg/ 6,14 mg comprimido recubierto

tuteur - comprimido recubierto - trifluridina 15 mg + tipiracilo 6,14 mg comprimido

FLONURISE 20 mg/ 8,19 mg comprimido recubierto Uruguay - spansk - Ministerio de Salud (Dirección Oficina Central)

flonurise 20 mg/ 8,19 mg comprimido recubierto

tuteur - comprimido recubierto - trifluridina 20 mg + tipiracilo 8,19 mg comprimido

TEMASTE 15 mg/6.14 mg comprimido recubierto Uruguay - spansk - Ministerio de Salud (Dirección Oficina Central)

temaste 15 mg/6.14 mg comprimido recubierto

gramon bago - comprimido recubierto - trifluridina 15 mg + tipiracilo 6,14 mg comprimido

TEMASTE 20 mg/8.19 mg comprimido recubierto Uruguay - spansk - Ministerio de Salud (Dirección Oficina Central)

temaste 20 mg/8.19 mg comprimido recubierto

gramon bago - comprimido recubierto - trifluridina 20 mg + tipiracilo 8,19 mg comprimido

Lonsurf Den europeiske union - engelsk - EMA (European Medicines Agency)

lonsurf

les laboratoires servier - trifluridine, tipiracil hydrochloride - colorectal neoplasms - antineoplastic agents - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents.lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

LONSURF TABLET Canada - engelsk - Health Canada

lonsurf tablet

taiho pharma canada, inc. - trifluridine; tipiracil (tipiracil hydrochloride) - tablet - 15mg; 6.14mg - trifluridine 15mg; tipiracil (tipiracil hydrochloride) 6.14mg - antineoplastic agents

LONSURF TABLET Canada - engelsk - Health Canada

lonsurf tablet

taiho pharma canada, inc. - trifluridine; tipiracil (tipiracil hydrochloride) - tablet - 20mg; 8.19mg - trifluridine 20mg; tipiracil (tipiracil hydrochloride) 8.19mg - antineoplastic agents

LONSURF Film-coated tablet Saudi-Arabia - engelsk - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

lonsurf film-coated tablet

les laboratories servier, france - trifluridine,tipiracil hydrochloride - film-coated tablet - 15,7.065 mg,

LONSURF Film-coated tablet Saudi-Arabia - engelsk - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

lonsurf film-coated tablet

les laboratories servier, france - trifluridine,tipiracil hydrochloride - film-coated tablet - 20,9.420 mg,